These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 32951963)
1. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas. Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963 [TBL] [Abstract][Full Text] [Related]
2. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer. Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116 [TBL] [Abstract][Full Text] [Related]
3. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing. Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466 [TBL] [Abstract][Full Text] [Related]
5. TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma. von Buchwald C; Jakobsen KK; Carlander AF; Tous S; Grønhøj C; Rasmussen JH; Brooks J; Taberna M; Mena M; Morey F; Bruni L; Batis N; Brakenhoff RH; René Leemans C; Jong RJB; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Anderson LA; Craig SG; Alemany L; Mehanna H; Eur J Cancer; 2024 Nov; 211():114329. PubMed ID: 39293346 [TBL] [Abstract][Full Text] [Related]
6. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan. Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391 [TBL] [Abstract][Full Text] [Related]
7. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma? Näsman A; Nordfors C; Holzhauser S; Vlastos A; Tertipis N; Hammar U; Hammarstedt-Nordenvall L; Marklund L; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T Eur J Cancer; 2015 Jan; 51(1):55-61. PubMed ID: 25466506 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status. Wendt M; Hammarstedt-Nordenvall L; Zupancic M; Friesland S; Landin D; Munck-Wikland E; Dalianis T; Näsman A; Marklund L Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070952 [TBL] [Abstract][Full Text] [Related]
9. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Nordfors C; Grün N; Tertipis N; Ährlund-Richter A; Haeggblom L; Sivars L; Du J; Nyberg T; Marklund L; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T Eur J Cancer; 2013 Jul; 49(11):2522-30. PubMed ID: 23571147 [TBL] [Abstract][Full Text] [Related]
10. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study. Garnaes E; Frederiksen K; Kiss K; Andersen L; Therkildsen MH; Franzmann MB; Specht L; Andersen E; Norrild B; Kjaer SK; von Buchwald C Int J Cancer; 2016 Dec; 139(11):2598-605. PubMed ID: 27537425 [TBL] [Abstract][Full Text] [Related]
11. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096 [TBL] [Abstract][Full Text] [Related]
12. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years. Haeggblom L; Ramqvist T; Tommasino M; Dalianis T; Näsman A Papillomavirus Res; 2017 Dec; 4():1-11. PubMed ID: 29179862 [TBL] [Abstract][Full Text] [Related]
13. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden. Haeggblom L; Attoff T; Yu J; Holzhauser S; Vlastos A; Mirzae L; Ährlund-Richter A; Munck-Wikland E; Marklund L; Hammarstedt-Nordenvall L; Ye W; Ramqvist T; Näsman A; Dalianis T Head Neck; 2019 Jun; 41(6):1583-1590. PubMed ID: 30584688 [TBL] [Abstract][Full Text] [Related]
14. Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome. Ramqvist T; Näsman A; Franzén B; Bersani C; Alexeyenko A; Becker S; Haeggblom L; Kolev A; Dalianis T; Munck-Wikland E Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587383 [TBL] [Abstract][Full Text] [Related]
15. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028 [TBL] [Abstract][Full Text] [Related]
16. A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer. Tertipis N; Hammar U; Näsman A; Vlastos A; Nordfors C; Grün N; Ährlund-Richter A; Sivars L; Haeggblom L; Marklund L; Hammarstedt-Nordenvall L; Chaturvedi AK; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T Eur J Cancer; 2015 Aug; 51(12):1580-7. PubMed ID: 26025766 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome. Bersani C; Haeggblom L; Ursu RG; Giusca SE; Marklund L; Ramqvist T; Näsman A; Dalianis T Anticancer Res; 2018 Aug; 38(8):4683-4690. PubMed ID: 30061236 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas. Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma. Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895 [TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival. Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]